Last updated: 2026-09-16 03:52:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Heartbeam, Inc. (BEAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0,43, with a market capitalisation of $22,90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,39 to $4,00. This page covers its latest market performance, valuation, price trends and company information.
$22,90M | |
$0,41 | |
$80,92 | |
$0,39 | |
$0,41 | |
668,40K | |
660,50K | |
-- | |
$4,00 | |
$0,39 | |
-- | |
-- |
Heartbeam, Inc. (BEAT) last closed at $0,41 as of 2026-09-16 00:00:00, unchanged from the previous close of $0,41.
During the latest regular trading session, BEAT traded between $0,39 and $80,92, with a volume of 668,40K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Heartbeam, Inc. (BEAT) moved from $0,42 to $0,43, representing a gain of 1,64% ($0,01).
The stock traded between $0,39 and $0,46 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 347,68 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1,0%
BEAT is currently trading at $0,43, placing it 1,0% of the way from its 52-week low of $0,39 to its 52-week high of $4,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 16 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Heartbeam, Inc. (BEAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.